<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36878812</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2212-1692</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Pediatrics and neonatology</Title><ISOAbbreviation>Pediatr Neonatol</ISOAbbreviation></Journal><ArticleTitle>Respiratory pathogen trends in patients with Kawasaki disease during the COVID-19 pandemic and respiratory syncytial virus epidemic in Japan.</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>511</EndPage><MedlinePgn>505-511</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pedneo.2023.01.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1875-9572(23)00031-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although the etiology of Kawasaki disease (KD) remains unknown, the most common view is that an infectious agent triggers the activation of the inflammatory cascade in predisposed children. The coronavirus disease 2019 (COVID-19) pandemic has led to the establishment of infection control measures, which reduced the overall incidence of respiratory infections; however, a resurgence of respiratory syncytial virus (RSV) infection occurred in the summer of 2021. This study aimed to examine the relationship between respiratory pathogens and KD during the COVID-19 pandemic and the RSV epidemic in Japan between 2020 and 2021.</AbstractText><AbstractText Label="METHODS">We retrospectively reviewed the medical charts of pediatric patients with KD or respiratory tract infection (RTI) admitted to National Hospital Organization Okayama Medical Center between December 1, 2020, and August 31, 2021. All patients with KD and RTI underwent multiplex polymerase chain reaction testing upon admission. We classified patients with KD into the three subgroups-pathogen-negative, single pathogen-positive, and multi-pathogen-positive-and compared their laboratory data and clinical features.</AbstractText><AbstractText Label="RESULTS">This study enrolled 48 patients with KD and 269 with RTI. Rhinovirus and enterovirus were the most prevalent pathogens in both patients with KD and RTI (13 [27.1%] and 132 patients [49.1%], respectively). The clinical characteristics of the pathogen-negative KD group and the pathogen-positive KD group at diagnosis were similar; however, the pathogen-negative group tended to receive additional treatment, such as multiple courses of intravenous immunoglobulin, intravenous methylprednisolone, infliximab, cyclosporine A, and plasmapheresis, more frequently. The number of patients with KD remained stable when RTI was not prevalent but increased following the surge in RTI with RSV.</AbstractText><AbstractText Label="CONCLUSIONS">An epidemic of respiratory infections led to an increase in the incidence of KD. Patients with respiratory pathogen-negative KD could have greater recalcitrance to intravenous immunoglobulin than those with respiratory pathogen-positive KD.</AbstractText><CopyrightInformation>Copyright © 2023 Taiwan Pediatric Association. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Namba</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Hospital Organization Okayama Medical Center, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higuchi</LastName><ForeName>Yousuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Hospital Organization Okayama Medical Center, Okayama, Japan. Electronic address: yhiguchi218@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Junya</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Hospital Organization Okayama Medical Center, Okayama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Pediatr Neonatol</MedlineTA><NlmUniqueID>101484755</NlmUniqueID><ISSNLinking>1875-9572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012136" MajorTopicYN="N">Respiratory Syncytial Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kawasaki disease</Keyword><Keyword MajorTopicYN="N">polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">respiratory tract infection</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>Conflicts of interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>6</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36878812</ArticleId><ArticleId IdType="pmc">PMC9937719</ArticleId><ArticleId IdType="doi">10.1016/j.pedneo.2023.01.001</ArticleId><ArticleId IdType="pii">S1875-9572(23)00031-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fukazawa R., Kobayashi J., Ayusawa M., Hamada H., Miura M., Mitani Y., et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J. 2020;84:1348–1407.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata S. Causes of Kawasaki disease-from past to present. Front Pediatr. 2019;7:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371652</ArticleId><ArticleId IdType="pubmed">30805322</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N., Rigante D., Esposito S. The role of infection in Kawasaki syndrome. J Infect. 2013;67:1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132405</ArticleId><ArticleId IdType="pubmed">23603251</ArticleId></ArticleIdList></Reference><Reference><Citation>Makino N., Nakamura Y., Yashiro M., Kosami K., Matsubara Y., Ae R., et al. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015–2016. Pediatr Int. 2019;61:397–403.</Citation><ArticleIdList><ArticleId IdType="pubmed">30786118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozeki Y., Yamada F., Saito A., Kishimoto T., Yashiro M., Makino N., et al. Epidemiologic features of Kawasaki disease distinguished by seasonal variation: an age-specific analysis. Ann Epidemiol. 2018;28:796–800.</Citation><ArticleIdList><ArticleId IdType="pubmed">30181018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumrah R., Vignesh P., Rawat A., Singh S. Immunogenetics of Kawasaki disease. Clin Rev Allergy Immunol. 2020;59:122–139.</Citation><ArticleIdList><ArticleId IdType="pubmed">32200494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Yu J.J., Lee J., Kim M.N., Ko H.K., Choi H.S., et al. Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease. Korean J Pediatr. 2012;55:470–473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534160</ArticleId><ArticleId IdType="pubmed">23300502</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnier J.L., Anderson M.S., Heizer H.R., Jone P.N., Glodé M.P., Dominguez S.R. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136:e609–e614.</Citation><ArticleIdList><ArticleId IdType="pubmed">26304824</ArticleId></ArticleIdList></Reference><Reference><Citation>Dionne A., Le C.K., Poupart S., Autmizguine J., Meloche-Dumas L., Turgeon J., et al. Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection. PLoS One. 2018;13:e0206001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192641</ArticleId><ArticleId IdType="pubmed">30332473</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson E.A., Mook P.A.N., Vandemaele K., Fitzner J., Hammond A., Cozza V., et al. Review of global influenza circulation, late 2019 to 2020, and the impact of the COVID-19 pandemic on influenza circulation. Wkly Epidemiol Rec. 2021;96:241–265.</Citation></Reference><Reference><Citation>PathWest Laboratory Medicine WA  . 2020. Paediatric respiratory pathogen reports.https://ww2.health.wa.gov.au/Articles/F_I/Infectious-disease-data/Paediatric-Respiratory-Pathogen-reports 2–3. Available from:</Citation></Reference><Reference><Citation>Pan American Health Organization  Regional update, influenza. https://www.paho.org/en/documents/regional-update-influenza-epidemiological-week-25-july-6-2021 Epidemiological week 25—July 6, 2021. 2021;1–36. Available at.</Citation></Reference><Reference><Citation>Ujiie M., Tsuzuki S., Nakamoto T., Iwamoto N. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis. 2021;27:2969–2970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544984</ArticleId><ArticleId IdType="pubmed">34388086</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  . 2021. The national respiratory and enteric virus surveillance system (NREVS); RSV national trends.https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html Available at.</Citation></Reference><Reference><Citation>Okayama prefecture infectious disease weekly report week 35, 2021. 2021. https://www.city.okayama.jp/kurashi/cmsfiles/contents/0000008/8327/2022025.pdf Available at.</Citation></Reference><Reference><Citation>Eckbo E.J., Locher K., Caza M., Li L., Lavergne V., Charles M. Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples. Diagn Microbiol Infect Dis. 2021;99</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7654322</ArticleId><ArticleId IdType="pubmed">33340934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Lu C.Y., Shao P.L., Lee P.I., Lin M.T., Fan T.Y., et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014;113:148–154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125523</ArticleId><ArticleId IdType="pubmed">24495555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R., Shibata Y., Kosami K., Nakamura Y., Hamada H. Kawasaki disease and pediatric infectious diseases during the coronavirus disease 2019 pandemic. J Pediatr. 2021;239:50–58.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591269</ArticleId><ArticleId IdType="pubmed">34324881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J.H., Kim Y.K., Min S.H., Kim S.W., Lee Y.H., Lee J.M. Seasonal trends of viral prevalence and incidence of Kawasaki disease: a Korea public health data analysis. J Clin Med. 2021;10:3301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347058</ArticleId><ArticleId IdType="pubmed">34362085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N., Pouletty M., Mariani P., Beyler C., Blachier A., Bonacorsi S., et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Heal. 2020;4:662–668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332278</ArticleId><ArticleId IdType="pubmed">32622376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Furuno K., Yamamura K., Kishimoto J., Mizuno Y., Murata K., et al. Assessment of pediatric admissions for Kawasaki disease or infectious disease during the COVID-19 state of emergency in Japan. JAMA Netw Open. 2021;4:e214475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025113</ArticleId><ArticleId IdType="pubmed">33822065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Kawasaki Disease Surveillance Team in Japan. No relationship was observed between Kawasaki disease and COVID-19 in Japan. Pediatr Int. 2021;63:977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242650</ArticleId><ArticleId IdType="pubmed">33913588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Akca U., Atalay E., Cuceoglu M.K., Balik Z., Sener S., Ozsurekci Y., et al. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol Int. 2022;42:51–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561687</ArticleId><ArticleId IdType="pubmed">34727197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwangbo J., Lee J.S., Choe S.A., Choe Y.J. Impact of social distancing on Kawasaki disease-associated hospitalization, South Korea. Pediatr Infect Dis J. 2021;40:e383–e384.</Citation><ArticleIdList><ArticleId IdType="pubmed">34030170</ArticleId></ArticleIdList></Reference><Reference><Citation>Phamduy T.T., Smith S., Herbst K.W., Phamduy P.T., Brimacombe M., Hogan A.H., et al. Kawasaki disease hospitalizations in the United States 2016–2020: a comparison of before and during the coronavirus disease 2019 era. Pediatr Infect Dis J. 2021;40:e407–e412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505141</ArticleId><ArticleId IdType="pubmed">34382611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeerdoss J., Pilania R.K., Karkhele R., Kumar T.S., Danda D., Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. 2021;41:19–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680080</ArticleId><ArticleId IdType="pubmed">33219837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hearn J., McCrindle B.W., Mueller B., O’Shea S., Bernknopf B., Labelle M., et al. Spatiotemporal clustering of cases of Kawasaki disease and associated coronary artery aneurysms in Canada. Sci Rep. 2018;8:17682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6281567</ArticleId><ArticleId IdType="pubmed">30518956</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., Lehtinen P., Vuorinen T., Koskenvuo M., Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004;72:695–699.</Citation><ArticleIdList><ArticleId IdType="pubmed">14981776</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>